Emicizumab prophylaxis for the treatment of infants with severe haemophilia A without factor VIII inhibitors: primary analysis of the HAVEN 7 study - Pipe, S W; Collins, P; Dhalluin, C; Kenet, G; Schmitt, C; Buri, M; Jimenez-Yuste, V; Peyvandi, F; Young, G; Oldenburg, J; Mancuso, M E; Kavakli, K; et al. (HAEMOPHILIA, 2024)